International Journal of Radiation Oncology * Biology * Physics
Volume 79, Issue 5 , Pages 1460-1466 , 1 April 2011

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4

Presented as a late-breaking abstract at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, September 22, 2008.

  • Robert C. Miller, M.D., M.S.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
    • Corresponding Author InformationReprint requests to: Robert C. Miller, M.D., M.S., Department of Radiation Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905
  • ,
  • David J. Schwartz, M.D.

      Affiliations

    • Minneapolis Radiation Oncology, P.A., Minneapolis, MN
  • ,
  • Jeff A. Sloan, Ph.D.

      Affiliations

    • Division of Biomedical Informatics and Biostatistics, Mayo Clinic, Rochester, MN
  • ,
  • Patricia C. Griffin, M.D.

      Affiliations

    • Upstate Carolina Community Clinic Oncology Program, Spartanburg, SC
  • ,
  • Richard L. Deming, M.D.

      Affiliations

    • Iowa Oncology Research Association Community Clinic Oncology Program, Des Moines, Iowa
  • ,
  • Jon C. Anders, M.D.

      Affiliations

    • Wichita Community Clinical Oncology Program, Wichita, KS
  • ,
  • Thomas J. Stoffel, M.D.

      Affiliations

    • Cedar Rapids Oncology Project Community Clinic Oncology Program, Cedar Rapids, IA
  • ,
  • Robert E. Haselow, M.D.

      Affiliations

    • Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN
  • ,
  • Paul L. Schaefer, M.D.

      Affiliations

    • Toledo Community Hospital Oncology Program Community Clinic Oncology Program, Toledo, OH
  • ,
  • James D. Bearden III, M.D.

      Affiliations

    • Upstate Carolina Community Clinic Oncology Program, Spartanburg, SC
  • ,
  • Pamela J. Atherton, M.S.

      Affiliations

    • Division of Biomedical Informatics and Biostatistics, Mayo Clinic, Rochester, MN
  • ,
  • Charles L. Loprinzi, M.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
  • ,
  • James A. Martenson, M.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN

Received 11 September 2009 ,Revised 19 November 2009 ,Accepted 2 January 2010.

References 

  1. Hopewell JW. The skin: Its structure and response to ionizing radiation. Int J Radiat Biol. 1990;57:751–773
  2. Bostrom A, Lindman H, Swartling C, et al. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double-blind, randomized study. Radiother Oncol. 2001;59:257–265
  3. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys. 2000;48:1307–1310
  4. Wells M, Macmillan M, Raab G, et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol. 2004;73:153–162
  5. Wickline MM. Prevention and treatment of acute radiation dermatitis: A literature review. Oncol Nurs Forum. 2004;31:237–247
  6. Williams MS, Burk M, Loprinzi CL, et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys. 1996;36:345–349
  7. Cancer Therapy Evaluation Program [Internet]. Rockville, MD: National Cancer Institute [cited 2009 Feb 4]. Common Terminology Criteria for Adverse Events v3.0 (CTCAE); 2006 Aug 9 [cited 2009 Feb 4]. Available from: www.ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed November 20, 2008.
  8. Chren MM, Lasek RJ, Sahay AP, et al. Measurement properties of Skindex-16: A brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105–110
  9. Berthelet E, Truong PT, Musso K, et al. Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol. 2004;27:626–631
  10. Bretscher M, Rummans T, Sloan J, et al. Quality of life in hospice patients: A pilot study. Psychosomatics. 1999;40:309–313
  11. Grunberg SM, Groshen S, Steingass S, et al. Comparison of conditional quality of life terminology and visual analogue scale measurements. Qual Life Res. 1996;5:65–72
  12. Gudex C, Dolan P, Kind P, et al. Health state valuations from the general public using the visual analogue scale. Qual Life Res. 1996;5:521–531
  13. Hyland ME, Sodergren SC. Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Qual Life Res. 1996;5:469–480
  14. Freedman GM, Anderson PR, Li J, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006;29:66–70
  15. Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995;31:1171–1185
  16. Boisnic S, Branchet-Gumila MC, Nizri D, et al. Histochemical and biochemical modifications induced by experimental irradiation of human skin maintained in survival conditions and modulation by application of an emulsion containing trolamine. Int J Tissue React. 2003;25:9–18
  17. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 1992;89:9991–9995
  18. Halperin EC, Gaspar L, George S, et al. for the CNS Cancer Consortium A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys. 1993;26:413–416
  19. Heggie S, Bryant GP, Tripcony L, et al. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 2002;25:442–451
  20. Liguori V, Guillemin C, Pesce GF, et al. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol. 1997;42:155–161
  21. Lokkevik E, Skovlund E, Reitan JB, et al. Skin treatment with bepanthen cream versus no cream during radiotherapy: A randomized controlled trial. Acta Oncol. 1996;35:1021–1026
  22. Vuong T, Franco E, Lehnert S, et al. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys. 2004;59:809–814
  23. Marshall AH. The action cortisone on experimental acute roentgen dermatitis. Acta Radiol. 1953;39:73–77
  24. Scott A, Kalz F. The effect of the topical application of corticotrophin, hydrocortisone, and fluorocortisone on the process of cutaneous inflammation. J Invest Dermatol. 1956;26:361–378
  25. Bjornberg A, Hellgren L, Olsson S. Treatment of radiation dermatitis with fluocinolone acetonide. Acta Radiol Ther Phys Biol. 1965;3:129–134
  26. Bjornberg A, Hellgren L, Magnusson B, et al. Topical treatment of radiation dermatitis with bethamethasone-17-valerate, Vaseline and Eucerine: A double-blind comparison. Clin Radiol. 1967;18:463–464
  27. Glees JP, Mameghan-Zadeh H, Sparkes CG. Effectiveness of topical steroids in the control of radiation dermatitis: A randomised trial using 1% hydrocortisone cream and 0.05% clobetasone butyrate (Eumovate). Clin Radiol. 1979;30:397–403
  28. Huter KA, Muller HG. [Radiation reaction of the skin in the use of glucocorticoids (German).]. Strahlentherapie. 1959;108:475–477
  29. Potera ME, Lookingbill DP, Stryker JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology. 1982;143:775–777
  30. Schmuth M, Wimmer MA, Hofer S, et al. Topical corticosteroid therapy for acute radiation dermatitis: A prospective, randomized, double-blind study. Br J Dermatol. 2002;146:983–991
  31. Sloan JA, Berk L, Roscoe J, et al. for the National Cancer Institute Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007;25:5070–5077
  32. Trotti A, Colevas AD, Setser A, et al. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25:5121–5127

 Conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and supported by U.S. National Institutes of Health Grant CA 124477 (principal investigator, Charles Loprinzi, M.D.).

 Conflict of interest: none.

PII: S0360-3016(10)00131-8

doi: 10.1016/j.ijrobp.2010.01.031

International Journal of Radiation Oncology * Biology * Physics
Volume 79, Issue 5 , Pages 1460-1466 , 1 April 2011